Hydrea (Hydroxyurea) – a new generation medicine
Hydrea (Hydroxyurea) is indicated for treating prolonged myeloproliferative syndromes (chronic myeloblastic leukemia, erythremia, idiopathic thrombocythemia, osteomyelofibrosis), ovarian and cervical carcinoma, skin cancer, colon cancer, brain tumor and melanoma in case other cytostatics turned ineffective or are not tolerated by patient. Hydrea (Hydroxyurea) is taken before meal with some water. The dosage of Hydrea (Hydroxyurea) for [...]